B cell growth-promoting activity of recombinant human interleukin 4
- PMID: 3112225
B cell growth-promoting activity of recombinant human interleukin 4
Abstract
Human interleukin 4 (IL-4), also known as B cell stimulatory factor 1, is a T cell-derived glycoprotein consisting of 129 amino acids for which a cDNA has been recently isolated. IL-4 displays little or no B cell growth factor (BCGF) activity in the standard anti-IgM costimulatory assay using suboptimal concentrations of soluble anti-IgM antibody whereas the low m.w. BCGF is very active. When insolubilized anti-IgM was used as the costimulating agent, both IL-4 and the low m.w. BCGF were found to promote B cell proliferation. Human IL-4 is able to induce the proliferation of B lymphocytes preactivated for either 1 day with insolubilized anti-IgM antibody or for 3 days with Staphylococcus aureus strain Cowan I. However, IL-4 is poorly mitogenic for B cells preactivated for 1 day with the Staphylococcus strain whereas the low m.w. BCGF strongly enhances the proliferation of these B cells. These two findings demonstrate that the preactivation signal necessary to induce human B cells to proliferate in response to IL-4 is critical. The increased tritiated thymidine ([3H]dThd) uptake in preactivated B cell cultures with IL-4 reflects cel proliferation because cell cycle analysis demonstrates that IL-4 induces activated B cells to enter the S and G2/M phases of the cell cycle and the addition of IL-4 to preactivated B cell cultures permits the recovery of three- to fourfold more B cells after 4 days of culture. IL-4 and the low m.w. BCGF act in concert to induce the proliferation of anti-IgM-preactivated B cells as demonstrated by [3H]dThd uptake and cell cycle analysis. In striking contrast to the demonstrated antagonistic effect of interferon-gamma on the IL-4-induced expression of the low affinity receptor for IgE (Fc epsilon RL/CD23), on B cells, it was found that interferon-gamma enhanced the IL-4-induced proliferation of anti-IgM-preactivated B cells. Finally, it was found that IL-4 had to be present continuously during the culture period to exert an optimal growth-promoting effect on B cell blasts. As a conclusion, IL-4 is able to induce the proliferation of an appropriately activated subpopulation of human B cells.
Similar articles
-
Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.J Immunol. 1986 Dec 15;137(12):3861-7. J Immunol. 1986. PMID: 3097134
-
Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.J Immunol. 1987 Apr 15;138(8):2554-60. J Immunol. 1987. PMID: 3031160
-
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.Eur J Immunol. 1986 Jun;16(6):623-9. doi: 10.1002/eji.1830160607. Eur J Immunol. 1986. PMID: 3087756
-
Regulatory effects of IL-4 on human B-cell response to IL-2.Eur Cytokine Netw. 1990 May-Jun;1(2):57-64. Eur Cytokine Netw. 1990. PMID: 2102812 Review.
-
Regulation of human B lymphocyte activation, proliferation, and differentiation.Adv Immunol. 1987;40:1-59. doi: 10.1016/s0065-2776(08)60237-0. Adv Immunol. 1987. PMID: 3109220 Review. No abstract available.
Cited by
-
Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.Immunology. 1991 Jun;73(2):217-21. Immunology. 1991. PMID: 2071166 Free PMC article.
-
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.J Exp Med. 1991 Mar 1;173(3):705-10. doi: 10.1084/jem.173.3.705. J Exp Med. 1991. PMID: 1705282 Free PMC article.
-
Functions of interleukin-4 on human B lymphocytes.Immunol Res. 1991;10(3-4):423-7. doi: 10.1007/BF02919735. Immunol Res. 1991. PMID: 1955770 Review. No abstract available.
-
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.Prostate Cancer Prostatic Dis. 2018 Jun;21(2):228-237. doi: 10.1038/s41391-017-0029-2. Epub 2018 Jan 3. Prostate Cancer Prostatic Dis. 2018. PMID: 29298992 Free PMC article.
-
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.J Clin Invest. 1994 Jul;94(1):97-104. doi: 10.1172/JCI117354. J Clin Invest. 1994. PMID: 7518836 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials